What is the recommended dosing schedule for amantadine (twice-daily) for treating tremors?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amantadine Dosing for Tremor

For treating tremor with amantadine, the recommended twice-daily dosing is 100 mg twice daily (morning and evening) for adults, with adjustments needed for special populations. 1

Standard Adult Dosing

  • The standard adult dosage of amantadine for treating tremor is 200 mg per day, administered as 100 mg twice daily 1
  • If central nervous system effects develop with once-daily dosing, splitting the dose into twice daily administration may reduce such complaints 1
  • Twice-daily dosing provides more consistent blood levels throughout the day, which is important for symptom control 1

Special Population Considerations

Elderly Patients (65 years and older)

  • For persons 65 years of age or older, the daily dosage should be reduced to 100 mg (50 mg twice daily) due to age-related decline in renal function 2, 1
  • The lower dose in elderly patients helps minimize the risk of central nervous system side effects while maintaining efficacy 2

Pediatric Dosing

  • For children 10-12 years of age, the recommended dosage is 100 mg twice daily 2
  • For children 1-9 years of age requiring amantadine, the dosage should be 5 mg/kg/day up to 150 mg in two divided doses 2
  • Children weighing less than 40 kg (88 lb) should receive 5 mg/kg/day regardless of age, divided into two doses 2

Renal Impairment Adjustments

  • A reduction in dosage is recommended for patients with creatinine clearance <50 mL/min/1.73m² 2
  • The drug package insert should be consulted for specific dosage recommendations based on creatinine clearance 2
  • Patients with renal impairment should be observed carefully for adverse reactions, and further dose reduction may be necessary 2

Titration and Monitoring

  • When initiating therapy, particularly in patients with serious medical illnesses, start with 100 mg daily for the first week 1
  • After one to several weeks at 100 mg daily, the dose may be increased to 100 mg twice daily if necessary 1
  • Monitor for common side effects including nervousness, anxiety, insomnia, difficulty concentrating, and lightheadedness 2
  • Be vigilant for signs of myoclonus following amantadine initiation, which although rare, has been reported as an adverse effect 3

Important Considerations

  • Effectiveness for essential tremor may be limited; a randomized controlled trial showed amantadine at 100 mg twice daily was not effective for essential tremor 4
  • Benefit may diminish after a few months of treatment; increasing the dose to 300 mg daily (in divided doses) may regain effectiveness in some patients 1
  • Temporary discontinuation followed by reinitiation may help regain benefit in patients who experience diminished effectiveness over time 1
  • For patients with extrapyramidal symptoms, amantadine has shown promising benefits, though dosing should be carefully monitored 5

Administration Timing

  • For twice-daily dosing, administer doses approximately 12 hours apart to maintain consistent blood levels throughout the day 1
  • If sleep disturbances occur, avoid taking the second dose too close to bedtime 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Effect of amantadine in essential tremor: a randomized, placebo-controlled trial.

Movement disorders : official journal of the Movement Disorder Society, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.